Renova Therapeutics Raises $7.52M
socalTECH
NOVEMBER 18, 2014
The company said the funding primarily came from high net worth individuals. Bradbury has joined the company''s board. Bradbury is a member of life sciences consulting and investment firm BioBrit LLC; he also served as President and CEO of Amylin Pharmaceuticals. As part of the funding, Daniel M. READ MORE>>.
138 
Let's personalize your content